Annual report
7716.TEDINET S100QHRO
Period2022-01-01 → 2022-12-31
Filed2023-03-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥48.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥44.9bn | 2021-01-01 → 2021-12-31 | Cons. | Net sales |
| Revenue | ¥33.1bn | 2020-01-01 → 2020-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥35.4bn | 2019-01-01 → 2019-12-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.5bn | 2018-01-01 → 2018-12-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥15.4bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥13.8bn | 2021-01-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥17.6bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥14.0bn | 2021-01-01 → 2021-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥8.6bn | 2020-01-01 → 2020-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.8bn | 2019-01-01 → 2019-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥10.7bn | 2018-01-01 → 2018-12-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥17.3bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥13.9bn | 2021-01-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥12.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥10.1bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6.5bn | 2020-01-01 → 2020-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.1bn | 2019-01-01 → 2019-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.6bn | 2018-01-01 → 2018-12-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥12.5bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥10.1bn | 2021-01-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥102.2bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥94.5bn | at 2021-12-31 | Cons. | Assets |
| Total assets | ¥82.5bn | at 2020-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥77.5bn | at 2019-12-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥73.3bn | at 2018-12-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.1bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥11.5bn | at 2021-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥91.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥82.9bn | at 2021-12-31 | Cons. | Net assets |
| Net assets / equity | ¥76.3bn | at 2020-12-31d | Cons. | Net assets |
| Net assets / equity | ¥72.5bn | at 2019-12-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥67.1bn | at 2018-12-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥35.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥36.0bn | at 2021-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥31.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥34.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.0bn | at 2020-12-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥24.7bn | at 2019-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥24.9bn | at 2018-12-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥7.8bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥12.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.2bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.0bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.7bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥6.3bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.1bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.3bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.7bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥6.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.0bn | 2021-01-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.7bn | 2020-01-01 → 2020-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.8bn | 2019-01-01 → 2019-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.5bn | 2018-01-01 → 2018-12-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥145.48 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.73 | 2021-01-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥74.49 | 2020-01-01 → 2020-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.97 | 2019-01-01 → 2019-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥87.59 | 2018-01-01 → 2018-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥145.11 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.47 | 2021-01-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥74.34 | 2020-01-01 → 2020-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥81.8 | 2019-01-01 → 2019-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥87.42 | 2018-01-01 → 2018-12-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,065.57 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥959.59 | at 2021-12-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥877.95 | at 2020-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥834.32 | at 2019-12-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥772.74 | at 2018-12-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 88.8% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 87.5% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.3% | at 2020-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.2% | at 2019-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 91.4% | at 2018-12-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.4% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2021-01-01 → 2021-12-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2020-01-01 → 2020-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.2% | 2019-01-01 → 2019-12-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.7% | 2018-01-01 → 2018-12-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,478 | at 2022-12-31 | Cons. | Number of employees |
| Employees | 1,239 | at 2021-12-31 | Cons. | Number of employees |
| Employees | 1,184 | at 2020-12-31d | Cons. | Number of employees |
| Employees | 1,159 | at 2019-12-31d | Cons. | Number of employees |
| Employees | 1,083 | at 2018-12-31d | Cons. | Number of employees |
| Revenue | ¥34.4bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥32.9bn | 2021-01-01 → 2021-12-31 | Standalone | Net sales |
| Revenue | ¥25.3bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥26.4bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥28.0bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥10.8bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | ¥9.6bn | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | ¥15.7bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥9.8bn | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥6.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.2bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥15.1bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥9.8bn | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | ¥11.8bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥7.2bn | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | ¥4.7bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥4.8bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥7.3bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥77.1bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥71.6bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥65.9bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥63.5bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥61.1bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.2bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥7.1bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥69.9bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥64.6bn | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥61.8bn | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥60.1bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥56.5bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥19.2bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥22.5bn | at 2021-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥137.22 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥82.97 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥54.48 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.45 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.42 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥136.88 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥82.79 | 2021-01-01 → 2021-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥54.37 | 2020-01-01 → 2020-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.33 | 2019-01-01 → 2019-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥84.26 | 2018-01-01 → 2018-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥46 | 2022-01-01 → 2022-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥37 | 2021-01-01 → 2021-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2020-01-01 → 2020-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥30 | 2019-01-01 → 2019-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥31 | 2018-01-01 → 2018-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥817.09 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥746.98 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥710.8 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥690.85 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥650.66 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 90.3% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 93.4% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 94.3% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.3% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 17.6% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.4% | 2021-01-01 → 2021-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.8% | 2020-01-01 → 2020-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.3% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.5% | 2018-01-01 → 2018-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 94,259,400 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,259,400 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,004 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 906 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 869 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 850 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 806 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-01-01 → 2022-12-31 | ¥1.0bn |
| Reconciling Itemsreconciling | depreciation | 2022-01-01 → 2022-12-31 | ¥490m |
| Reconciling Itemsreconciling | segment assets | at 2022-12-31 | ¥61.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-12-31 | −¥4.9bn |
| Dental Productsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥2.2bn |
| Dental Productsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥1.2bn |
| Dental Productsreportable segment | employees | at 2022-12-31 | 729 pure |
| Dental Productsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥40.9bn |
| Dental Productsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥40.9bn |
| Dental Productsreportable segment | segment assets | at 2022-12-31 | ¥28.8bn |
| Dental Productsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥17.0bn |
| Industrial Productsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥464m |
| Industrial Productsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥209m |
| Industrial Productsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥4.6bn |
| Industrial Productsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥4.6bn |
| Industrial Productsreportable segment | segment assets | at 2022-12-31 | ¥8.8bn |
| Industrial Productsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥1.7bn |
| Surgical Productsreportable segment | capex | 2022-01-01 → 2022-12-31 | ¥390m |
| Surgical Productsreportable segment | depreciation | 2022-01-01 → 2022-12-31 | ¥179m |
| Surgical Productsreportable segment | employees | at 2022-12-31 | 112 pure |
| Surgical Productsreportable segment | revenue | 2022-01-01 → 2022-12-31 | ¥3.2bn |
| Surgical Productsreportable segment | revenue external | 2022-01-01 → 2022-12-31 | ¥3.2bn |
| Surgical Productsreportable segment | segment assets | at 2022-12-31 | ¥2.7bn |
| Surgical Productsreportable segment | segment profit | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| —segment total | capex | 2022-01-01 → 2022-12-31 | ¥3.0bn |
| —segment total | depreciation | 2022-01-01 → 2022-12-31 | ¥1.6bn |
| —segment total | revenue | 2022-01-01 → 2022-12-31 | ¥48.7bn |
| —segment total | revenue external | 2022-01-01 → 2022-12-31 | ¥48.7bn |
| —segment total | segment assets | at 2022-12-31 | ¥40.4bn |
| —segment total | segment profit | 2022-01-01 → 2022-12-31 | ¥20.3bn |
| Reconciling Itemsreconciling | capex | 2021-01-01 → 2021-12-31 | ¥516m |
| Reconciling Itemsreconciling | depreciation | 2021-01-01 → 2021-12-31 | ¥444m |
| Reconciling Itemsreconciling | segment assets | at 2021-12-31 | ¥63.3bn |
| Reconciling Itemsreconciling | segment profit | 2021-01-01 → 2021-12-31 | −¥4.5bn |
| Dental Productsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥1.5bn |
| Dental Productsreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥1.0bn |
| Dental Productsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥38.3bn |
| Dental Productsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥38.3bn |
| Dental Productsreportable segment | segment assets | at 2021-12-31 | ¥25.7bn |
| Dental Productsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥15.6bn |
| Industrial Productsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥229m |
| Industrial Productsreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥189m |
| Industrial Productsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥3.8bn |
| Industrial Productsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥3.8bn |
| Industrial Productsreportable segment | segment assets | at 2021-12-31 | ¥3.3bn |
| Industrial Productsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥1.4bn |
| Surgical Productsreportable segment | capex | 2021-01-01 → 2021-12-31 | ¥199m |
| Surgical Productsreportable segment | depreciation | 2021-01-01 → 2021-12-31 | ¥167m |
| Surgical Productsreportable segment | revenue | 2021-01-01 → 2021-12-31 | ¥2.8bn |
| Surgical Productsreportable segment | revenue external | 2021-01-01 → 2021-12-31 | ¥2.8bn |
| Surgical Productsreportable segment | segment assets | at 2021-12-31 | ¥2.2bn |
| Surgical Productsreportable segment | segment profit | 2021-01-01 → 2021-12-31 | ¥1.3bn |
| —segment total | capex | 2021-01-01 → 2021-12-31 | ¥1.9bn |
| —segment total | depreciation | 2021-01-01 → 2021-12-31 | ¥1.4bn |
| —segment total | revenue | 2021-01-01 → 2021-12-31 | ¥44.9bn |
| —segment total | revenue external | 2021-01-01 → 2021-12-31 | ¥44.9bn |
| —segment total | segment assets | at 2021-12-31 | ¥31.2bn |
| —segment total | segment profit | 2021-01-01 → 2021-12-31 | ¥18.2bn |
| Dental Productsreportable segment | employees | at 2022-12-31 | 473 pure |
| Surgical Productsreportable segment | employees | at 2022-12-31 | 102 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,540
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | Prior1YearInstant | 94460919000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant | 102154460000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 772.74 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 834.32 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 877.95 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 959.59 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 1065.57 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 87.59 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 81.97 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 74.49 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 116.73 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 145.48 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | 87.42 | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | 81.80 | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | 74.34 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 116.47 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | 145.11 | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.914 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.932 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.923 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.875 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.888 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.117 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.102 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.087 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.127 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.144 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | 21.3 | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | 25.4 | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 30.4 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 18.1 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 17.6 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 8680294000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 7021964000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | 9183986000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 11970529000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 7764417000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -1725256000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -4321986000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -1380698000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -4146968000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -6314202000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | -2455110000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -2772322000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | -2685794000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -3973487000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -6107521000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 24919850000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 24669800000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 30044771000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |